$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Detailed introduction to the pharmacological mechanism of Pretomanid and its principle of action against multidrug-resistant tuberculosis
2026-02-01 22:25:32
Check Details
What is voclosporin? Full analysis of pharmacological effects, indications and clinical use
2026-02-01 22:25:32
Check Details
Full analysis of ponatinib drug information and clinical research data
2026-02-01 22:25:32
Check Details
Safinamide Mesylate Tablets (Sittaco) Instructions and Indications, Pharmacology and Clinical Application Analysis
2026-02-01 22:25:32
Check Details
Can Tarlatamab-Imdelltra cure small cell lung cancer and its clinical efficacy and data analysis
2026-02-01 22:25:32
Check Details
Telisotuzumab-EMRELIS medical insurance reimbursement conditions and policy and cost explanations in different regions
2026-02-01 22:25:32
Check Details
Comparison of the efficacy of tovorafenib and trametinib, as well as treatment options and clinical references for different patients
2026-02-01 22:25:32
Check Details
Comparative analysis of the differences, indications, efficacy and use of vorasidenib-VORANIGO and fluconazole
2026-02-01 22:25:32
Check Details
Zongatinib (Zongatinib) launch time and patient purchase channel description
2026-02-01 22:25:32
Check Details
The price of vosoritide, the market reference cost for different courses of treatment and the description of the drug purchase plan
2026-02-01 22:25:32
Check Details
Recommended instructions for the correct usage, dosage and taking time of Mecobalamin tablets
2026-02-01 22:25:32
Check Details
Whether cobimetinib (cobimetinib) has officially entered the Chinese market and the progress of registration approval
2026-02-01 22:25:32
Check Details
1
2
...
2297
2298
2299
2300
2301
2302
2303
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
2
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
3
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
4
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
5
Pretomanid for Drug-Resistant TB: Risks and Management of 3-Year Treatment
6
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
7
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
8
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
9
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
10
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
11
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
12
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment